No Improvement in OS or PFS from Sacituzumab Govitecan Compared with Chemotherapy In Pretreated Patients with Advanced Urothelial Cancer By Ogkologos - March 24, 2025 423 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TROPiCS-04 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR Courageous children receive Star Awards in virtual celebration December 17, 2021 How Finding the Right Primary Care Physician During Cancer Has Helped... March 24, 2021 Rescued From Complete Darkness July 1, 2021 Here’s Why We’re Building Pet-Friendly Domestic Violence Shelters–And How You Can... October 18, 2021 Load more HOT NEWS Beating cancer by improving the public’s health: the road ahead in... Heine H. Hansen Award: Johan Vansteenkiste and Fiona Blackhall Honoured for... New Treatments for Non-Small Cell Lung Cancer With an EGFR Mutation:... Insulin Resistance May Contribute to Poorer Breast Cancer Outcomes, Study Says
